These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31903940)

  • 21. Can emerging drug classes improve R&D productivity?
    Meier C; Cairns-Smith S; Schulze U
    Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmaceutical industry needs more clinical pharmacologists.
    Peck R
    Br J Clin Pharmacol; 2017 Nov; 83(11):2343-2346. PubMed ID: 28688130
    [No Abstract]   [Full Text] [Related]  

  • 23. ESDR 2010-2020: Journey toward Translational and Systems Dermatology.
    Schmuth M; Biedermann T; Picardo M; Florestan T; Barker J
    J Invest Dermatol; 2020 Sep; 140(9S):S167-S170. PubMed ID: 32800164
    [No Abstract]   [Full Text] [Related]  

  • 24. Singapore's salad days are over.
    Nature; 2010 Dec; 468(7325):731. PubMed ID: 21150947
    [No Abstract]   [Full Text] [Related]  

  • 25. Are mAbs different?: a comment on Cohen and Wilson.
    Neumann PJ
    MAbs; 2009; 1(1):29-30. PubMed ID: 20046571
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality Control of Therapeutic Monoclonal Antibodies at the Hospital After Their Compounding and Before Their Administration to Patients.
    Jaccoulet E; Smadja C; Taverna M
    Methods Mol Biol; 2016; 1466():179-84. PubMed ID: 27473490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer research needs a better map.
    Boehm JS; Garnett MJ; Adams DJ; Francies HE; Golub TR; Hahn WC; Iorio F; McFarland JM; Parts L; Vazquez F
    Nature; 2021 Jan; 589(7843):514-516. PubMed ID: 33500573
    [No Abstract]   [Full Text] [Related]  

  • 28. [From a crisis to another...Pharmaceutical industry--economics].
    Scheen AJ
    Rev Med Liege; 2009 Jan; 64(1):3-5. PubMed ID: 19317093
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Riskiest ideas' win $50 million from Chan Zuckerberg Biohub.
    Maxmen A
    Nature; 2017 Feb; 542(7641):280-281. PubMed ID: 28202988
    [No Abstract]   [Full Text] [Related]  

  • 30. [Introduction and welcome message].
    Schwebig A; Levy N; Ayme S
    Presse Med; 2012 May; 41 Suppl 1():S1-2. PubMed ID: 22483772
    [No Abstract]   [Full Text] [Related]  

  • 31. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 32. Biomedical research. Bristol-Myers ends no-strings grants.
    Kaiser J
    Science; 2006 Jun; 312(5778):1289. PubMed ID: 16741080
    [No Abstract]   [Full Text] [Related]  

  • 33. Pfizer slashes R&D.
    Cressey D
    Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
    [No Abstract]   [Full Text] [Related]  

  • 34. Perspective of clinical research in follicular NHL: interaction between science and industry.
    Fine G; Horning S
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):313-21. PubMed ID: 21658627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug discovery veers off target.
    Shaffer C
    Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A word from the coordinators].
    Pèlegrin A; Beck A; Watier H
    Med Sci (Paris); 2019 Dec; 35(12):923. PubMed ID: 31903894
    [No Abstract]   [Full Text] [Related]  

  • 37. [EMABling
    de Romeuf C
    Med Sci (Paris); 2019 Dec; 35(12):1160-1162. PubMed ID: 31903931
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 39. How do we re-engage the pharmaceutical industry in research on serotonin and psychiatric disorders?
    Green AR; Marsden CA
    ACS Chem Neurosci; 2013 Jan; 4(1):9-12. PubMed ID: 23336037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where will new drugs come from?
    Lancet; 2011 Jan; 377(9760):97. PubMed ID: 21215869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.